CAS: 190383-13-2 - H-Ser-Leu-Ile-Gly-Lys-Val-NH2
Formula:C28H54N8O7
- Sinonimi:
- Protease-Activated Receptor-2 Agonist, Amide
- Proteinase Activated Receptor 2 (1-6) Amide (Human)
- Proteinase Activated Receptor 2 Agonist Peptide Sligkv Amide, Human
- Ser-Leu-Ile-Gly-Lys-Val-Amide
- Ser-Leu-Ile-Gly-Lys-Val-Nh2
- Sligkvamide
- Sligkv-Nh2
- Par-2 Agonist Peptide (Sligkv) Amide, Human
PAR-2 (1-6) amide (human)
CAS:190383-13-2
SLIGKV-amide, which corresponds to the tethered ligand sequence of human PAR-2 (protease activated receptor 2), …
Formula:
C28H54N8O7
Purezza:
> 98%
Colore e forma:
White Lyophilisate
Peso molecolare:
614.79
Ref: 01-4029152
25mg | 308,00 € | ||
100mg | 899,00 € |
Consegna stimata in Stati Uniti, il Martedì 12 Novembre 2024
Ref: 7W-GK4405
Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Lunedì 18 Novembre 2024
Protease-Activated Receptor-2, amide
CAS:190383-13-2
Protease-Activated Receptor-2, amide (SLIGKV-NH2) is an agonist of PAR2 (IC50 : 10.4 M)
Formula:
C28H54N8O7
Purezza:
100%
Colore e forma:
Solid
Peso molecolare:
614.78
Ref: TM-T7513
2mg | 52,00 € | ||
5mg | 75,00 € | ||
10mg | 114,00 € | ||
25mg | 187,00 € | ||
50mg | 282,00 € | ||
100mg | 421,00 € |
Consegna stimata in Stati Uniti, il Venerdì 22 Novembre 2024
H-Ser-Leu-Ile-Gly-Lys-Val-NH2
CAS:190383-13-2
H-Ser-Leu-Ile-Gly-Lys-Val-NH2 is a synthetic peptide that is a cyclase inhibitor. It binds to the receptor …
Formula:
C25H54N8O7
Purezza:
Min. 95%
Peso molecolare:
614.79 g/mol
Ref: 3D-PAR-3889-PI
1mg | 156,00 € | ||
5mg | 467,00 € |
Consegna stimata in Stati Uniti, il Martedì 26 Novembre 2024
PAR-2 (1-6) amide (human) trifluoroacetate salt
CAS:190383-13-2
PAR-2 (1-6) amide (human) trifluoroacetate salt H-Ser-Leu-Ile-Gly-Lys-Val-NH2 trifluoroacetate salt is a protease inhibitor that inhibits …
Formula:
C28H54N8O7
Purezza:
Min. 95%
Peso molecolare:
614.78 g/mol
Ref: 3D-FP109317
10mg | 292,00 € | ||
25mg | 488,00 € | ||
50mg | 808,00 € | ||
100mg | 1.322,00 € | ||
250mg | 2.876,00 € |
Consegna stimata in Stati Uniti, il Venerdì 10 Gennaio 2025